Unresectable or medically inoperable non-small cell lung cancer: The use of established clinical prognostic factors in making radiation-related treatment decisions

Seminars in Radiation Oncology

Volumn 10, Issue 4, 2000, Pages 267-273

  Sawyer, Timothy E ^a   Bonner, James A ^a,b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHOSCOPY; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; PLEURA EFFUSION; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 0033788094     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1053/srao.2000.9130     Document Type: Article

References (31)

1. Prognostic factors in non-small cell lung cancer
2. Prognostic implications of the international staging system for lung cancer
3. A new international staging system for lung cancer
4. Prognostic factors for survival in patients with inoperable lung cancer
5. The role of surgery in N2 lung cancer
6. Bronchogenic carcinoma: Analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling
7. Roentgenographic evaluation of mediastinal nodes for preoperative assessment in lung cancer
8. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung
9. Radiation therapy in the management of medically inoperable carcinoma of the lung: Results and implications for future treatment strategies
10. Prognostic factors in the treatment of node-negative nonsmall cell lung carcinoma with radiotherapy alone
11. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: The Duke experience
12. Improved survival in stage III non-small-cell lung cancer: Seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial
13. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer
14. Local irradiation alone for peripheral stage I lung cancer: Could we omit the elective regional nodal irradiation?
15. Curative radiotherapy for technically operable stage I nonsmall cell lung cancer
16. Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: A retrospective analysis of 149 patients
17. Predictors of subclinical nodal involvement in clinical stages I and II non-small cell lung cancer: Implications in the inoperable and three-dimensional dose-escalation settings
18. Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer
19. The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer
20. Lung carcinoma
21. Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy
22. Prognostic factors in inoperable adenocarcinoma of the lung: A multivariate regression analysis of 259 patients
23. Recursive partitioning analysis of 1,592 patients on four Radiation Therapy Oncology Group studies in inoperable non-small cell lung cancer
24. Pleural effusion as a significant prognostic factor in non-small cell lung cancer
25. Prognostic value of pleural effusion in patients with non-small cell lung cancer
26. The staging of lung cancer
27. Survival with inoperable lung cancer: An integration of prognostic variables based on simple clinical criteria
28. Long-term survivors in metastatic non-small-cell lung cancer: An Eastern Cooperative Oncology Group Study
29. Is prolonged survival possible for patients with supraclavicular node metastases in non-small cell lung cancer treated with chemoradiotherapy? Analysis of the Radiation Therapy Oncology Group experience
30. Cytologically proved malignant pleural effusions: Distribution of transudates and exudates
31. Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1,547 patients on four Radiation Therapy Oncology Group (RTOG) studies in inoperable nonsmall-cell lung cancer (NSCLC)